Israel Englander Omeros Corp Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Omeros Corp stock. As of the latest transaction made, Millennium Management LLC holds 315,252 shares of OMER stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

315,252

Previous 85,671 267.98%

Holding current value

$1.1 Million

Previous $846,000 206.26%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$7.04 - $11.21 $1.62 Million - $2.57 Million	229,581 Added 267.98%	315,252 $2.59 Million
Q4 2024 Feb 14, 2025	BUY	$3.77 - $12.15 $102,121 - $329,119	27,088 Added 46.24%	85,671 $846,000
Q3 2024 Nov 14, 2024	BUY	$3.54 - $5.47 $147,299 - $227,606	41,610 Added 245.15%	58,583 $232,000
Q2 2024 Aug 14, 2024	SELL	$3.04 - $4.23 $29,314 - $40,789	-9,643 Reduced 36.23%	16,973 $68,000
Q1 2024 May 15, 2024	BUY	$2.88 - $4.89 $46,068 - $78,220	15,996 Added 150.62%	26,616 $91,000
Q4 2023 Feb 14, 2024	SELL	$1.08 - $3.63 $362,063 - $1.22 Million	-335,244 Reduced 96.93%	10,620 $34,000
Q2 2023 Aug 14, 2023	BUY	$4.45 - $7.57 $51,304 - $87,274	11,529 Added 3.45%	345,864 $1.88 Million
Q1 2023 May 15, 2023	SELL	$2.48 - $5.22 $47,261 - $99,477	-19,057 Reduced 5.39%	334,335 $1.56 Million
Q4 2022 Feb 14, 2023	SELL	$1.75 - $3.96 $266,000 - $601,920	-152,000 Reduced 30.08%	353,392 $799,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $7.46 $2.21 Million - $5.34 Million	-715,390 Reduced 58.6%	505,392 $1.59 Million
Q2 2022 Aug 15, 2022	BUY	$1.92 - $6.28 $1.53 Million - $5.01 Million	797,034 Added 188.09%	1,220,782 $3.36 Million
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $3.79 Million - $5.38 Million	-746,755 Reduced 63.8%	423,748 $2.55 Million
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $5.55 Million - $8.35 Million	978,261 Added 508.87%	1,170,503 $7.53 Million
Q3 2021 Nov 15, 2021	SELL	$13.4 - $16.3 $1.99 Million - $2.42 Million	-148,554 Reduced 43.59%	192,242 $2.65 Million
Q2 2021 Aug 16, 2021	BUY	$14.81 - $19.13 $2.56 Million - $3.3 Million	172,702 Added 102.74%	340,796 $5.06 Million
Q1 2021 May 17, 2021	SELL	$14.52 - $23.53 $4.66 Million - $7.56 Million	-321,110 Reduced 65.64%	168,094 $2.99 Million
Q4 2020 Feb 16, 2021	BUY	$10.14 - $15.19 $2.06 Million - $3.09 Million	203,264 Added 71.09%	489,204 $6.99 Million
Q3 2020 Nov 16, 2020	BUY	$9.57 - $21.32 $2.74 Million - $6.1 Million	285,940 New	285,940 $2.89 Million
Q2 2020 Aug 14, 2020	SELL	$12.21 - $16.99 $2.46 Million - $3.43 Million	-201,798 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$9.03 - $19.72 $1.82 Million - $3.98 Million	201,798 New	201,798 $2.7 Million
Q3 2019 Nov 14, 2019	SELL	$14.55 - $20.56 $9.98 Million - $14.1 Million	-686,235 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$15.0 - $19.62 $8.99 Million - $11.8 Million	599,399 Added 690.27%	686,235 $10.8 Million
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.62 $9.92 Million - $13 Million	-661,456 Reduced 88.4%	86,836 $1.4 Million
Q1 2019 May 14, 2019	SELL	$11.65 - $17.72 $4.24 Million - $6.46 Million	-364,292 Reduced 32.74%	748,292 $13 Million
Q4 2018 Feb 14, 2019	BUY	$10.72 - $16.73 $10.7 Million - $16.6 Million	994,829 Added 844.83%	1,112,584 $12.4 Million
Q3 2018 Nov 14, 2018	SELL	$17.73 - $26.69 $6.23 Million - $9.38 Million	-351,517 Reduced 74.91%	117,755 $2.87 Million
Q2 2018 Aug 14, 2018	BUY	$10.79 - $24.44 $5.06 Million - $11.5 Million	469,272 New	469,272 $8.51 Million
Q1 2018 May 15, 2018	SELL	$9.0 - $20.16 $428,346 - $959,495	-47,594 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.26 - $22.86 $631,096 - $1.09 Million	47,594	47,594 $925,000

Others Institutions Holding OMER

# of Institutions

150

Shares Held

27.8M

Call Options Held

369K

Put Options Held

697K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $218M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account